该案件暴露的根本问题，在于预防出血共识与报销规定之间的冲突，以及医学进步与政策更新的不同 步。当"预防治疗"已成为主流方案，医保仍将报销范围限定于"出血后"，这种滞后性不仅影响患者的诊 疗质量，更可能造成长期医疗成本上升，如患者因出血导致关节残疾后的康复费用要远高于预防用药支 出等。 医保报销条件不应仅是财务核算工具，更应成为引导合理医疗行为的指挥棒。若医保始终固守旧规，总 是搞"一刀切"禁止，类似的"被迫违规"可能还会上演。 24岁的血友病患者叶胜乐因用药摊上事了。起诉书显示，叶胜乐涉嫌骗取医保基金，应以诈骗罪追究刑 事责任。而且，被起诉的不只这一名血友病患者。 据新京报记者多方查证，浙江温州、嘉兴、宁波等地区多位医药代表以及多家民营医院（涉及院长、药 房主任、医生等）、配药公司负责人、第三方护士等超50人，均成为这一系列医保诈骗案的被告人。 检方指控，该系列案件的犯罪模式是医药代表、配药公司、民营医院达成三方协议，以返点模式准入相 关药品，再以0元购加返利诱导患者前往医院，虚构出血事实大量购药，骗取大额医保基金。 假如单从医保制度的角度来看，此案被定性为骗保无可厚非。医保基金严格遵循"专款专用、真实发 生 ...

Group 1 - By 2025, the national medical insurance system will continue to improve its functions, with basic insurance coverage stable at 95% and reimbursement rates for employee and resident insurance at approximately 80% and 70% respectively, enhancing public health welfare [1] - In 2025, the reimbursement rate for rural disadvantaged groups will exceed 90%, with all 31 provinces and regions achieving intra-provincial pooling of employee insurance personal accounts and 337 areas realizing inter-provincial pooling [1] - Currently, 95% of pooling areas directly distribute maternity benefits to insured individuals, with 31 provinces including assisted reproductive projects in medical insurance, and 7 provinces achieving "no out-of-pocket" expenses for inpatient childbirth [3] Group 2 - In 2025, 114 new drugs will be added to the medical insurance catalog, and the National Medical Insurance Administration will establish a commercial health insurance innovative drug catalog, including 19 highly innovative drugs that significantly benefit patients [5] - Over the past five years, through big data models and intelligent regulatory subsystems, the medical insurance fund has recovered losses of 9.5 billion yuan, with over 100 billion drug traceability codes collected to combat illegal activities [7] - By 2025, 1.25 billion people will have activated their medical insurance codes for medical treatment and drug purchases, with plans to build the world's largest medical insurance imaging cloud, aiming for nationwide interoperability of imaging data by the end of 2027 [7]

Core Viewpoint - The article highlights the misuse of medical insurance cards for purchasing everyday items disguised as medical devices, which threatens the integrity of personal medical accounts and the overall healthcare funding system [1][11]. Group 1: Misuse of Medical Insurance Funds - Everyday products like toothbrushes and face masks are being rebranded as medical devices, allowing them to be sold in pharmacies and purchased with medical insurance cards [1][4]. - Some individuals and companies are exploiting loopholes in the system to divert funds from personal medical accounts, which are intended for essential healthcare needs [5][19]. - Reports indicate that certain companies have successfully marketed everyday items as medical devices, leading to significant sales through insurance reimbursements, such as a company that sold "medical isolation pads" and generated 90 million yuan in orders [4][14]. Group 2: Regulatory and Systemic Issues - The 2021 guidelines from the State Council aimed to ensure that personal medical accounts are used for legitimate medical expenses, but some entities have found ways to circumvent these regulations [16][17]. - There is a need for clearer definitions and stricter regulations regarding what constitutes a medical device to prevent non-medical items from being classified as such [20][22]. - The article calls for a reevaluation of the medical insurance fund's usage to ensure that it is directed towards genuine healthcare needs, rather than being misappropriated for non-essential purchases [20][22]. Group 3: Public Awareness and Responsibility - Many cardholders mistakenly believe that the funds in their medical accounts are their own to spend freely, leading to unintentional complicity in the misuse of these funds [19]. - The article emphasizes the importance of public awareness and responsibility in protecting medical insurance funds from exploitation [22].